\
&
Contact us
\
&
Contact us
Published on | 3 years ago
Programmes HealthThe results of the evaluation are:
Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs - HORIZON-HLTH-2022-DISEASE-06-02-two-stage
Vaccines 2.0 - developing the next generation of vaccines - HORIZON-HLTH-2022-DISEASE-06-03-two-stage
Development of new effective therapies for rare diseases - HORIZON-HLTH-2022-DISEASE-06-04-two-stage
In accordance with General Annex D of the Work Programme, the evaluation of the first-stage proposals was made looking only at the criteria 'excellence' and 'impact'. The threshold for both individual criteria is 4. The overall threshold applying to the sum of the two individual scores was set at a level that ensures the total requested budget of proposals admitted to stage 2 is as close as possible to three times the available budget, and not less than two and a half times the available budget, and is as follows:
Source: Funding & Tenders Portal (Funding Updates)
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities.
The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.
